Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986;21(1):26-30.
doi: 10.1007/BF00199373.

The effect of RU 41.740 (Biostim) on the production of interleukin-1 by monocytes and enriched large granular lymphocytes in normals and patients with hepatocellular carcinoma

J Herman, M C Kew, A R Rabson

The effect of RU 41.740 (Biostim) on the production of interleukin-1 by monocytes and enriched large granular lymphocytes in normals and patients with hepatocellular carcinoma

J Herman et al. Cancer Immunol Immunother. 1986.

Abstract

The effect of RU 41.740 on natural killer (NK) cell cytotoxicity from normals and patients with advanced hepatocellular carcinoma (HCC) was studied. RU 41.740-treated normal enriched large granular lymphocytes (LGLs) showed increased cytotoxic activity against 51Cr-labelled K562 cells. Although the drug increased the cytotoxic activity of LGLs from HCC patients, these results were not statistically significant. As LGLs have been shown to release interleukin-1 (IL-1) after suitable stimulation the effects of RU 41.740 on production of this cytokine from both monocytes and LGLs was studied. The drug stimulated IL-1 release from normal cells but monocyte and LGL IL-1 production from HCC patients was not influenced by RU 41.740 by RU 41.740. It is concluded, therefore, that although RU 41.740 can stimulate natural cytotoxicity and IL-1 production by normal LGLs, it is unable to correct the defect which exists in these functions in patients with large mass tumours.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Dempsey RA, Dinarello CA, Mier JW, Rosenwasser LS, Allegretta M, Brown TE, Parkinson DR. The differential effects of human leucocyte pyrogen/lymphocyte activating factor, T cell growth factor and interferon on human natural killer activity. J Immunol. 1982;129:2504. - PubMed
    1. Droller MJ, Schneider MV, Perlman P. A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumour cells. Cell Immunol. 1978;39:165. - PubMed
    1. Duff GW, Atkins E. The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production. J Immunol Methods. 1982;52:333. - PubMed
    1. Falkoff RJM, Murguchi A, Hong J, Butler JL, Dinarello CA, Fauci AS. The effects of interleukin 1 on human B cell activation and proliferation. J Immunol. 1983;131:801. - PubMed
    1. Griscelli C, Grospierre B, Montreuil J, Fournet B, Bruvier G, Lang JM, Marchiani C, Zaliser R, Edelstein R. Immunomodulation by glycoprotein fractions isolated from Klebsiella pneumoniae. In: Yamamura Y, Kotani S, editors. Immunomodulation by microbial products and related synthetic compounds. Amsterdam: Exerpta Medica; 1982. p. 261.

MeSH terms